Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1999
11/09/1999CA2157750C Photocleavable sequestering agents and compositions thereof
11/09/1999CA2106452C Amidinophenol derivatives
11/09/1999CA2102321C Partial liquid breathing of fluorocarbons
11/09/1999CA2065111C Ionically crosslinked carboxyl-containing polysaccharides for adhesion prevention
11/04/1999WO1999055903A1 Membrane-permeant phosphoinositides
11/04/1999WO1999055893A1 Retroviral vectors including modified envelope escort proteins
11/04/1999WO1999055868A2 Fizz proteins
11/04/1999WO1999055867A1 Delayed rectifier potassium channel subunit
11/04/1999WO1999055859A2 Cd40-interacting and traf-interacting proteins
11/04/1999WO1999055845A1 Cellular and animal models for diseases associated with altered mitochondrial function
11/04/1999WO1999055830A2 Process for synthesizing cox-2 inhibitors
11/04/1999WO1999055735A1 G-csf receptor agonist antibodies and screening method therefor
11/04/1999WO1999055734A1 A g-protein coupled 7tm receptor (axor-1)
11/04/1999WO1999055733A1 Cloning of a novel 7tm receptor axor-2
11/04/1999WO1999055725A1 Functionalized alkyl and alkenyl side chain derivatives of glycinamides as farnesyl transferase inhibitors
11/04/1999WO1999055723A1 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
11/04/1999WO1999055711A1 Treatment of mastitis
11/04/1999WO1999055708A1 Condensed thienopyrimidines with phosphodiesterase-v inhibiting action
11/04/1999WO1999055697A1 Serotonergic agents
11/04/1999WO1999055696A1 New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same
11/04/1999WO1999055695A1 Indolyl derivatives as serotonergic agents
11/04/1999WO1999055694A1 Indolyl derivatives as serotonergic agents
11/04/1999WO1999055681A1 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same
11/04/1999WO1999055680A1 Aryl fused azapolycyclic compounds
11/04/1999WO1999055678A1 Quinoline derivatives
11/04/1999WO1999055672A2 Antipsychotic indolyl derivatives
11/04/1999WO1999055667A1 N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
11/04/1999WO1999055663A1 Inhibitors of impdh enzyme
11/04/1999WO1999055388A1 Substituted porphyrins
11/04/1999WO1999055376A1 Peg-lhrh analog conjugates
11/04/1999WO1999055371A1 Solution containing nicotine
11/04/1999WO1999055354A1 Fertility improving composition and application thereof
11/04/1999WO1999055343A1 Cnre binding factors and uses thereof
11/04/1999WO1999055339A1 Adenosine a1 receptor antagonist containing composition and method for restoring diuretic and renal function
11/04/1999WO1999055335A1 Substituted tricyclic pyrazole derivatives with protein kinase activity
11/04/1999WO1999055330A1 Ccr-3 receptor antagonists
11/04/1999WO1999055324A1 Ccr-3 receptor antagonists
11/04/1999WO1999055323A1 Use of nmda antagonists for treatment of irritable bowel syndrome
11/04/1999WO1999055322A1 Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
11/04/1999WO1999055321A1 Compounds and methods for treating mitochondria-associated diseases
11/04/1999WO1999055315A1 Periadventitial delivery device
11/04/1999WO1999055308A1 Aqueous composition comprising active ingredients for the de-pigmentation of the skin
11/04/1999WO1999055298A1 Food compositions, compositions for oral cavity and medicinal compositions for preventing or treating periodontosis and method for preventing or treating periodontosis
11/04/1999WO1999055159A1 Serotonin potentiation by oleamide analogs
11/04/1999WO1999045909A3 Use of nitrone compounds for the inhibition of angiogenesis
11/04/1999WO1999031074A3 ((cyclo)alkyl substituted)-.gamma.-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders
11/04/1999WO1998027073A8 Asymmetric synthesis of benzoxazinones
11/04/1999DE19819548A1 Biphenylderivate Biphenyl
11/04/1999DE19819023A1 Thienopyrimidine Thienopyrimidines
11/04/1999CA2330644A1 Solution containing nicotine
11/04/1999CA2330577A1 Serotonergic agents
11/04/1999CA2330576A1 Substituted benzazocines as nicotine-binding inhibitors
11/04/1999CA2330452A1 Antipsychotic indolyl derivatives
11/04/1999CA2330448A1 Peg-lhrh analog conjugates
11/04/1999CA2330437A1 Indolyl derivatives as serotonergic agents
11/04/1999CA2330436A1 Indolyl derivatives as serotonergic agents
11/04/1999CA2330428A1 Treatment of mastitis
11/04/1999CA2329982A1 Membrane-permeant phosphoinositides
11/04/1999CA2329821A1 Ccr-3 receptor antagonists
11/04/1999CA2329777A1 Ccr-3 receptor antagonists
11/04/1999CA2329709A1 Compounds and methods for treating mitochondria-associated diseases
11/04/1999CA2329328A1 Use of nmda antagonists for treatment of irritable bowel syndrome
11/04/1999CA2328929A1 Serotonin potentiation by oleamide analogs
11/04/1999CA2327504A1 Cd40-interacting and traf-interacting proteins
11/04/1999CA2326755A1 G-csf receptor agonist antibodies and screening method therefor
11/04/1999CA2326233A1 Delayed rectifier potassium channel subunit
11/04/1999CA2326114A1 Periadventitial delivery device
11/04/1999CA2326001A1 Fizz proteins
11/04/1999CA2324251A1 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
11/03/1999EP0953636A2 Cytokine signal regulators
11/03/1999EP0953570A1 Fluorinated cephalosporin antibiotics and their use for the treatment of mastitis
11/03/1999EP0953567A2 Bicyclic substituted piperazine-, piperidine- and tetrahydropyridine derivatives, their preparation and their use as agents with central dopaminergic (dopamine D4 receptor) activity
11/03/1999EP0953338A1 Packaging device for a product
11/03/1999EP0952837A1 Use of mixtures of active substances, containing phytostenols and/or phytostenol esters and potentiators, for the production of hypocholesteremic agents
11/03/1999EP0952836A1 New use
11/03/1999EP0952832A1 Quinoline carboxamides as tnf inhibitors and as pde-iv inhibitors
11/03/1999EP0952830A1 Use of raloxifene and of related compounds for the manufacture of a medicament for lowering plasma levels of lipoprotein(a)
11/03/1999EP0763055B1 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
11/03/1999EP0744944B1 Sexual steroid-containing transdermal therapeutic systems
11/03/1999EP0693051B1 Cyclopentene and cyclopentane derivatives as endothelin receptor antagonists
11/03/1999CN1234077A Structural and functional conservation of C. Elegans clock gene clk-1
11/03/1999CN1234073A Circularly permuted erythropoietin receptor agonists
11/03/1999CN1234072A Anti-ErbB2 antibodies
11/03/1999CN1234071A Keratinocyte grouth factor -2(KGF-2 or fibroblast growth factor-12, FGF-12)
11/03/1999CN1234039A 3-mercaptoacetylamino-1,5-subsd. 2-oxo-azepon derivatives useful as inhibitor of metrix metalloproteinase
11/03/1999CN1234037A Subsd. aminoalkane phosphonic acids
11/03/1999CN1234032A Novel 2,4-dioxopyrrolidine and 2,4-dioxotetrahydrofuran derivatives and medicines contg. same as active ingredient
11/03/1999CN1234031A Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the prodn. of tumor necrosis factor (TNF)
11/03/1999CN1234026A Piperazino derivatives as neurokinin antagonists
11/03/1999CN1234024A 4-aminoethoxy indolone derivatives
11/03/1999CN1234023A 4-aminoethoxy indoes as dopamin D2 agonists and as 5HT1A ligands
11/03/1999CN1233962A Use of Ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition contg. same
11/03/1999CN1233957A Pharmaceutical compositions
11/02/1999USRE36375 Treatment of Alzheimer's disease using azacyclic compounds
11/02/1999US5977382 Benzo[b]thiophene compounds, intermediates, processes, compositions, and methods
11/02/1999US5977367 N-aminoalkyldibenzofurancarboxamides; new dopamine receptor subtype specific ligands
11/02/1999US5977359 Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present
11/02/1999US5977338 Polynucleotides which hybridize with naturally occurring sequences encoding human interferon-inducible protein (hifi) and the polynucleotides which identify and encode hifi.
11/02/1999US5977328 Reacting a carbohydrate having at least one monosaccharide unit with a partially protected starch, removing the protecting groups, and purifying product; bactericides, parasiticides; preventing formation of/or disrupting biofilms
11/02/1999US5977296 Chiral peptide nucleic acid monomers and oligomers
1 ... 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 ... 1564